Project Grant R56AG089689
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded University of California, Los Angeles a $534,287 Project Grant on September 30, 2025, under the Aging Research program (CFDA 93.866) to develop the CONNECT-AD Study, a research initiative examining communication and network navigation for effective care teams in Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). The study leverages social network analysis, machine learning-assisted visual analytics,...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $2.7 million Project Grant to the University of California, Los Angeles (UCLA) under the Aging Research program (CFDA 93.866) to conduct a four-year comparative outcomes study examining post-acute care discharge destinations for older patients with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The research will utilize Veterans Affairs electronic health record data from approximately 100 VA...
- This $1,933,556 Project Grant awarded by the National Institute on Aging (NIA) under its Aging Research program (CFDA 93.866) will support research to assess the impact of hospital-based health information technology (hospital-HIT) on healthcare quality and equity for patients with Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Maryland, College Park, will conduct a ten-year longitudinal study to evaluate how hospital-HIT systems that promote care...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant of $690,934 to the University of California, Davis, with an award date of March 1, 2026, and completion date of November 30, 2030, under the Aging Research program (CFDA 93.866). This research project addresses subjective cognitive decline (SCD) as an early indicator of Alzheimer's Disease and Related Dementias (AD/ADRD) across diverse racial and ethnic populations. The research will examine how...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded $632,507 to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center under the Aging Research program (CFDA 93.866) effective September 25, 2025, with completion targeted for August 31, 2030. This Project Grant supports a Type 2 hybrid effectiveness-implementation study examining the scalability and real-world implementation of Time Limited Trials (TLTs) in intensive care unit (ICU) settings. The...
- Federal Project Grant Award Summary The National Institute on Aging awarded UC San Diego a $165,488 Project Grant (CFDA 93.866, Aging Research program) effective March 1, 2026, through November 30, 2028, to develop artificial intelligence-driven biomarker identification for reducing misdiagnosis in Alzheimer's disease. The project addresses the critical challenge of AD misdiagnosis rates reaching 25%, which result in inappropriate treatments in 18-67% of cases and undermine research reliability....
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of California, Berkeley a $1,079,604 Project Grant on May 15, 2025, under the Aging Research program (CFDA 93.866) to conduct research on heterogeneous causal pathophysiology in Alzheimer's disease (AD). The primary deliverables include the development of novel statistical methodologies for causal discovery that will identify population-specific pathophysiological pathways underlying AD progression....
- Federal Grant Award Summary Grant Details: The National Institute on Aging (NIA) awarded a Project Grant totaling $3,424,229 to the University of California, Davis on September 15, 2025, under the Aging Research program (CFDA 93.866). The project, with a completion date of September 14, 2029, addresses critical gaps in understanding the relationship between social health and cognitive decline in Alzheimer's disease and related dementias (AD/ADRDS). Deliverables and Research Objectives: The...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Michigan a $303,449 project grant effective June 1, 2025, through May 31, 2027, under the Aging Research program (CFDA 93.866) to investigate the genomic impact of transposable elements (TEs) in Alzheimer's disease and related dementias (ADRD). The research will leverage large-scale genomic datasets and clinical information from major Alzheimer's disease cohorts to overcome analytical challenges...
- Federal Grant Award Summary The National Institute on Aging awarded the University of California, Irvine a $3.22 million Project Grant under the Aging Research program (CFDA 93.866) on September 15, 2025, with a completion date of August 31, 2029. This research initiative examines the role of the retrosplenial cortex (RSC) in Alzheimer's disease (AD) pathogenesis through translational investigation combining mouse models and human studies. The primary deliverables include scientific findings...
The University of California, Los Angeles received a $643,139 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) for the "Comparative and Cost-Effectiveness of Personalized Targeted Multi-Factorial Approaches to Reducing Disparities in Alzheimer's Disease and Related Dementias" (TARDIS-AD Project). The award, issued on September 30, 2025, with completion targeted for August 31, 2027, funds research aimed at identifying personalized intervention strategies to reduce disparities in dementia risk across socioeconomic, racial/ethnic, and gender populations. The research team will leverage expertise in causal mediation analysis, machine learning, and simulation modeling to examine how lifestyle factors, metabolic markers (such as hemoglobin A1C and inflammation), and psychosocial factors interact to influence Alzheimer's disease and related dementias (ADRD) risk, with particular focus on understanding these relationships within disparate populations. The project will deliver comprehensive research deliverables including quantified assessments of biological and psychosocial factor contributions to dementia disparities, personalized intervention strategies optimized for cost-effectiveness, and policy-relevant analyses examining trade-offs between population health maximization and health disparities minimization. By systematically analyzing the complex interrelationships among lifestyle, metabolic, and psychosocial factors, the TARDIS-AD Project will generate evidence to inform the development of targeted, effective interventions for reducing dementia-related health disparities—addressing a critical gap in current knowledge, as prior studies have not adequately examined these intersecting factors or their differential effects across demographic groups.TARDIS-AD Project Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $643.1k | 9/26/25 |